Self-amplified ROS production from fatty acid oxidation enhanced tumor immunotherapy by atorvastatin/PD-L1 siRNA lipopeptide nanoplexes
- 2 November 2022
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 291, 121902
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Shenyang Municipal Bureau of Science and Technology
- Shenyang Pharmaceutical University
This publication has 60 references indexed in Scilit:
- Immunogenic cell death and DAMPs in cancer therapyNature Reviews Cancer, 2012
- Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinaseMetabolism, 2012
- AMPK: a nutrient and energy sensor that maintains energy homeostasisNature Reviews Molecular Cell Biology, 2012
- Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptidesJournal of Controlled Release, 2011
- Exposure to Hydrogen Peroxide Induces Oxidation and Activation of AMP-activated Protein Kinase*Journal of Biological Chemistry, 2010
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nature Reviews Drug Discovery, 2009
- Atorvastatin prevents carbohydrate response element binding protein activation in the fructose‐fed rat by activating protein kinase A†Hepatology, 2008
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Interaction of Polycationic Polymers with Supported Lipid Bilayers and Cells: Nanoscale Hole Formation and Enhanced Membrane PermeabilityBioconjugate Chemistry, 2006
- Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase AJournal of Biological Chemistry, 2001